MarketPeel
Insider Trading Intelligence
JW

Jitendra Wadhane

PYXS
CHIEF ACCOUNTING OFFICER · PYXIS ONCOLOGY, INC. · CIK 0001941706
FILING MIX · LIFETIME93%/7%
BUYS
13
SELLS
1
TOTAL VALUE
$276.4K
COMPANIES
1
ACTIVE SINCE
Mar 2023
HOLDINGS NOW
262,635
AVG SELL PX
TRADE KIND
SHOWING 14 / 14
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Jitendra Wadhane, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+100.00%+13.36%-0.72%+14.08%+16.31%
14d3+100.00%+18.88%+0.74%+18.14%+14.59%
30d3+0.00%-8.82%-3.11%-5.72%-8.40%
60d3+0.00%-13.10%+5.77%-18.88%-18.26%
90d3+33.33%-2.13%+10.80%-12.93%-15.36%
180d3+100.00%+153.97%+22.04%+131.93%+102.71%
1y3+100.00%+111.68%+34.64%+77.05%+68.28%
2y3+100.00%+24.61%+57.49%-32.88%-34.10%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PYXS · 262,635 shares · as of Mar 24, 2026
0128,221256,441384,662512,882202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 13 buys / 1 sellsCOVERAGE · 13 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PYXS
PYXIS ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
109,461512,882Mar 24, 2026Mar 25, 2026View →
PYXS
PYXIS ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
262,635262,635Mar 24, 2026Mar 25, 2026View →
PYXS
PYXIS ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
263,782$0.98$258.5K263,782Mar 31, 2025Apr 2, 2025View →
PYXS
PYXIS ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
150,000150,000Dec 23, 2024Dec 23, 2024View →
PYXS
PYXIS ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
131,484398,421Mar 26, 2024Mar 28, 2024View →
PYXS
PYXIS ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
40,000266,937Nov 15, 2023Nov 17, 2023View →
PYXS
PYXIS ONCOLOGY, INC.
PURCHASE
Chief Accounting Officer
2,500$1.87$4.7K226,937Sep 27, 2023Sep 27, 2023View →
PYXS
PYXIS ONCOLOGY, INC.
PURCHASE
Chief Accounting Officer
5,000$1.77$8.8K224,437Sep 25, 2023Sep 25, 2023View →
PYXS
PYXIS ONCOLOGY, INC.
PURCHASE
Chief Accounting Officer
2,500$1.74$4.3K219,437Sep 22, 2023Sep 22, 2023View →
PYXS
PYXIS ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
93,896211,937Sep 7, 2023Sep 8, 2023View →
PYXS
PYXIS ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
29,393118,041Mar 24, 2023Mar 28, 2023View →
PYXS
PYXIS ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
45,00088,648Mar 24, 2023Mar 28, 2023View →
PYXS
PYXIS ONCOLOGY, INC.
SALE
Chief Accounting Officer
157,2570Mar 24, 2023Mar 28, 2023View →
PYXS
PYXIS ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
157,257157,257Mar 24, 2023Mar 28, 2023View →
Other insiders · PYXS
Loading peer insiders…
About this filer
CIK 0001941706
ROLE
Chief Accounting Officer
PRIMARY
PYXS
COMPANIES
1
ACTIVE SINCE
Mar 2023
MARKETPEEL · /INSIDER/0001941706DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback